Vedolizumab clearance in neonates, susceptibility to infections and developmental milestones: a prospective multicentre population‐based cohort study

Serious Infections in Children Born to Mothers With Inflammatory Bowel Disease With In Utero Exposure to Thiopurines and Anti-Tumor Necrosis Factor

(2021) Antoine Meyer et al.   Clinical Gastroenterology and Hepatology

Paediatric infections in the first 3 years of life after maternal anti-TNF treatment during pregnancy

(2020) Gabriella Bröms et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

In utero exposure to thiopurines/anti-TNF agents and long-term health outcomes during childhood and adolescence in Denmark

(2020) Bente Mertz Nørgård et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Long-term safety of vedolizumab for inflammatory bowel disease

(2020) Edward V. Loftus et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Health outcomes of 1000 children born to mothers with inflammatory bowel disease in their first 5 years of life

(2020) Shannon Linda Kanis et al.   GUT

Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel Disease

(2020) Uma Mahadevan et al.   GASTROENTEROLOGY

Inflammatory Bowel Disease (IBD) in Pregnancy Clinical Care Pathway – A Report from the American Gastroenterological Association IBD Parenthood Project Working Group

(2019) Uma Mahadevan et al.   GASTROENTEROLOGY

Anti-TNF Therapy in Pregnant Women With Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth Outcomes

(2019) Mette Julsgaard et al.   INFLAMMATORY BOWEL DISEASES

The REDCap consortium: Building an international community of software platform partners

(2019) Paul A. Harris et al.   JOURNAL OF BIOMEDICAL INFORMATICS

Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study

(2019) Annick Moens et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Letter: vedolizumab drug levels in cord and maternal blood in women with inflammatory bowel disease

(2018) M. Julsgaard et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study

(2018) M Chaparro et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Vedolizumab Concentrations in the Breast Milk of Nursing Mothers With Inflammatory Bowel Disease

(2018) Mette Julsgaard et al.   GASTROENTEROLOGY

Effects of Anti-Integrin Treatment With Vedolizumab on Immune Pathways and Cytokines in Inflammatory Bowel Diseases

(2018) Timo Rath et al.   Frontiers in Immunology

Vedolizumab safety in pregnancy and newborn outcomes

(2017) Mette Julsgaard et al.   GUT

Fecal Calprotectin Is Not Affected by Pregnancy

(2017) Mette Julsgaard et al.   INFLAMMATORY BOWEL DISEASES

The Effect of Disease Activity on Birth Outcomes in a Nationwide Cohort of Women with Moderate to Severe Inflammatory Bowel Disease

(2017) Heidi Kammerlander et al.   INFLAMMATORY BOWEL DISEASES

Vedolizumab Levels in Breast Milk of Nursing Mothers With Inflammatory Bowel Disease

(2017) Adi Lahat et al.   Journal of Crohns & Colitis

Preterm prelabor rupture of the membranes: A disease of the fetal membranes

(2017) Ramkumar Menon et al.   SEMINARS IN PERINATOLOGY

Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection

(2016) Mette Julsgaard et al.   GASTROENTEROLOGY

The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy

(2016) Geoffrey C. Nguyen et al.   GASTROENTEROLOGY

Placental Transport of Immunoglobulins: A Clinical Review for Gastroenterologists Who Prescribe Therapeutic Monoclonal Antibodies to Women During Conception and Pregnancy

(2008) Sunanda V Kane et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY